Back to search

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

Data up to Jan 2025

Published2012
Citations154
References36

Total Citations Per Year

Abstract

References (36)

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2012 • 16,041 citations

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2007 • 4,423 citations

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

2004 • 4,353 citations

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

2008 • 2,132 citations

The Measurement of Dyspnea

1984 • 1,291 citations

Outcomes for COPD pharmacological trials: from lung function to biomarkers

2008 • 817 citations

Measurement of Symptoms, Lung Hyperinflation, and Endurance during Exercise in Chronic Obstructive Pulmonary Disease

1998 • 534 citations

Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease

1999 • 491 citations

In Chronic Obstructive Pulmonary Disease, a Combination of Ipratropium and Albuterol Is More Effective Than Either Agent Alone

1994 • 358 citations

Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease

2010 • 347 citations

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD

2005 • 342 citations

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

2003 • 302 citations

Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest

2000 • 302 citations

Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD

2006 • 284 citations

Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD

2010 • 270 citations

Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis

2006 • 239 citations

Once-daily indacaterolversustwice-daily salmeterol for COPD: a placebo-controlled comparison

2010 • 212 citations

Distribution of Receptor Targets in the Lung

2004 • 204 citations

Cardiovascular Safety of Tiotropium in Patients With COPD

2009 • 183 citations

Formoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month study

2008 • 171 citations

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison

2012 • 154 citations

Routine Nebulized Ipratropium and Albuterol Together Are Better Than Either Alone in COPD

1997 • 145 citations

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

2011 • 139 citations

Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD

2009 • 136 citations

Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD

2011 • 120 citations

Factor Analysis of Changes in Dyspnea and Lung Function Parameters after Bronchodilation in Chronic Obstructive Pulmonary Disease

2000 • 119 citations

QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease

2010 • 116 citations

The Safety of Tiotropium — The FDA's Conclusions

2010 • 110 citations

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms

2010 • 99 citations

The Effect of Tiotropium on Hyperinflation and Exercise Capacity in Chronic Obstructive Pulmonary Disease

2005 • 98 citations

State of the Art Compendium: Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease

2004 • 96 citations

Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study

2011 • 96 citations

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium

2010 • 86 citations

Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease

2007 • 82 citations

Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: Systematic review with meta-analysis

2009 • 80 citations

Tiotropium HandiHaler® in the treatment of COPD: A safety review

2009 • 60 citations

Cited By (0)

Loading...